We provide continuous coverage of global stock markets with insights into earnings trends, valuation changes, and macroeconomic factors influencing equity prices.
This analysis evaluates investment positioning for Bristol-Myers Squibb (BMY) ahead of its first-quarter 2026 earnings release, scheduled for pre-market trading on April 30, 2026. Consensus estimates peg Q1 revenue at $10.94 billion and adjusted earnings per share (EPS) at $1.44. With the stock up 9
Bristol-Myers Squibb Company (BMY) – Pre-Q1 2026 Earnings Investment Outlook: Buy, Hold, or Sell? - Earnings Surprise Score
BMY - Stock Analysis
4015 Comments
1422 Likes
1
Paulyne
Expert Member
2 hours ago
{协议答案}
👍 263
Reply
2
Aagot
Legendary User
5 hours ago
{协议答案}
👍 62
Reply
3
Shamecca
Senior Contributor
1 day ago
{协议答案}
👍 234
Reply
4
Marlasia
Experienced Member
1 day ago
{协议答案}
👍 264
Reply
5
Jaquis
Elite Member
2 days ago
{协议答案}
👍 254
Reply
© 2026 Market Analysis. All data is for informational purposes only.